MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Medscape Hematology-Oncology Headlines' source. Wed, 08 Feb 2012 08:41:49 +0100 http://www.medworm.com/index.php?rid=5646909&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F757748%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F757748%3Fsrc%3Drss Hyperbaric oxygen improves most cases of chronic radiation tissue injury, according to a large single-center report. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5646909 Thu, 02 Feb 2012 11:19:19 +0100 5646909 http://www.medworm.com/index.php?rid=5580848&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F756610%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F756610%3Fsrc%3Drss In a reminder of how much a once-heralded area of cancer research has crumbled, a former Duke oncologist and his colleagues issued their eighth study retraction late last week. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5580848 Wed, 11 Jan 2012 02:46:32 +0100 5580848 http://www.medworm.com/index.php?rid=5523932&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F755692%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F755692%3Fsrc%3Drss Drs. Kathy Miller and George Sledge review the hits and misses in breast cancer research from SABCS 2011. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5523932 Mon, 19 Dec 2011 22:36:35 +0100 5523932 http://www.medworm.com/index.php?rid=5456840&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F754339%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F754339%3Fsrc%3Drss Ten-year survival rates are high when patients with unfavorable localized prostate cancer are treated with external beam radiotherapy boosted with conformal high-dose-rate brachytherapy. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5456840 Tue, 29 Nov 2011 21:21:56 +0100 5456840 http://www.medworm.com/index.php?rid=5431262&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F753895%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F753895%3Fsrc%3Drss After enucleation for high-risk retinoblastoma, VEC chemotherapy (vincristine, etoposide, carboplatin) very effectively prevents metastasis, according to a report from the Wills Eye Institute in Philadelphia. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5431262 Mon, 21 Nov 2011 23:17:13 +0100 5431262 http://www.medworm.com/index.php?rid=5421452&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F753600%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F753600%3Fsrc%3Drss Dr. John Marshall probes critical issues in fighting a smarter war against cancer, issues that will be addressed by all stakeholders in cancer care during a symposium in Washington, DC, December 1-3. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5421452 Thu, 17 Nov 2011 17:00:00 +0100 5421452 http://www.medworm.com/index.php?rid=5406995&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewcollection%2F32231%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewcollection%2F32231%3Fsrc%3Drss Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5406995 Mon, 14 Nov 2011 20:37:36 +0100 5406995 http://www.medworm.com/index.php?rid=5399993&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F752864%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F752864%3Fsrc%3Drss Dr. Bruce Cheson finds it spooky that a well-established investigator publishes a letter in NEJM questioning data from a previously published study in which he was the senior author. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5399993 Thu, 10 Nov 2011 17:00:00 +0100 5399993 http://www.medworm.com/index.php?rid=5359764&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F752439%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F752439%3Fsrc%3Drss Revised guidelines on cervical cancer screening, while reasonable, may not be in the best interest of individual patients, says Dr. Maurie Markman, and should not dictate practice. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5359764 Fri, 28 Oct 2011 16:00:00 +0100 5359764 http://www.medworm.com/index.php?rid=5313785&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F751313%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F751313%3Fsrc%3Drss Dr. Bruce Cheson says a new German study of alemtuzumab and fludarabine in relapsed CLL is somewhat irrelevant and the therapy significantly more toxic compared with other combination therapies. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5313785 Tue, 11 Oct 2011 16:00:00 +0100 5313785 http://www.medworm.com/index.php?rid=5296497&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F751162%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F751162%3Fsrc%3Drss Dr. John Marshall reflects on the progress made in the diagnosis and treatment of neuroendocrine pancreas cancer in the time since Steve Jobs’ diagnosis and the distance still needed to go to cure this disease. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5296497 Fri, 07 Oct 2011 16:00:00 +0100 5296497 http://www.medworm.com/index.php?rid=5273090&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F750562%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F750562%3Fsrc%3Drss With use of regional anesthesia, nonintubated thoracoscopic lobectomy is technically feasible and may be a good alternative to single-lung ventilation, Taiwanese researchers report. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5273090 Thu, 29 Sep 2011 23:06:04 +0100 5273090 http://www.medworm.com/index.php?rid=5260022&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F749984%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F749984%3Fsrc%3Drss Dr. John Marshall reflects on the unmet needs of caregivers of cancer patients who struggle to maintain family normalcy while caring for the patient, and resolves that doctors do more to help them. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5260022 Mon, 26 Sep 2011 16:00:00 +0100 5260022 http://www.medworm.com/index.php?rid=5260023&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewcollection%2F32157%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewcollection%2F32157%3Fsrc%3Drss Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5260023 Fri, 23 Sep 2011 17:55:56 +0100 5260023 http://www.medworm.com/index.php?rid=5207726&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F742141%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F742141%3Fsrc%3Drss Stereotactic radiotherapy has a high impact on overall survival in patients with early lung cancer, but it requires quality-assurance procedures, says Dr. Rafal Dziadziuszko at EMCTO 2011. ecancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5207726 Tue, 06 Sep 2011 16:00:00 +0100 5207726 http://www.medworm.com/index.php?rid=5183127&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F748755%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F748755%3Fsrc%3Drss Dr. David Kerr reports on a new assay that predicts chemosensitivity to a particular drug and suggests that this approach will prove a step forward for personalized medicine across a range of tumor types. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5183127 Wed, 31 Aug 2011 16:00:00 +0100 5183127 http://www.medworm.com/index.php?rid=5160832&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F748468%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F748468%3Fsrc%3Drss Dr. Maurie Markman reports on a gene discovery that couples increased risk for ovarian cancer with sensitivity to PARP inhibitors, suggesting treatment strategies for patients with the mutation. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5160832 Fri, 26 Aug 2011 16:00:00 +0100 5160832 http://www.medworm.com/index.php?rid=5142998&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F748291%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F748291%3Fsrc%3Drss Obesity is linked not only to more aggressive prostate cancer but also to larger tumors, Italian researchers report. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5142998 Fri, 19 Aug 2011 21:57:35 +0100 5142998 http://www.medworm.com/index.php?rid=5119584&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F747948%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F747948%3Fsrc%3Drss Music therapy can reduce anxiety and improve mood, pain, and quality of life in cancer patients. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5119584 Fri, 12 Aug 2011 14:14:31 +0100 5119584 http://www.medworm.com/index.php?rid=5078490&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F747195%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F747195%3Fsrc%3Drss Reirradiation plus hyperthermia is an effective treatment for radiation-associated sarcoma (RAS) and could even cure some of these rare tumors, a small new study suggests. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5078490 Sat, 30 Jul 2011 14:14:07 +0100 5078490 http://www.medworm.com/index.php?rid=5069906&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F747132%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F747132%3Fsrc%3Drss Children and adolescents who use cell phones are not at a statistically significant increased risk for brain cancer, according to a new international study. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5069906 Wed, 27 Jul 2011 20:14:16 +0100 5069906 http://www.medworm.com/index.php?rid=5029974&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F746372%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F746372%3Fsrc%3Drss Studying more than 2.8 million Danish adults, researchers found that those who'd used a cell phone for 11 to 15 years were no more likely than newer users or non-users to develop an acoustic neuroma. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5029974 Fri, 15 Jul 2011 18:43:05 +0100 5029974 http://www.medworm.com/index.php?rid=5029975&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F745888%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F745888%3Fsrc%3Drss Seeking medical care at the first symptom of ovarian cancer does not improve survival in a provocative study reported on by Dr. Maurie Markman. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5029975 Wed, 13 Jul 2011 16:00:00 +0100 5029975 http://www.medworm.com/index.php?rid=5009387&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F745598%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F745598%3Fsrc%3Drss The PARAMOUNT trial answers an important question: Is there a role for continuation of maintenance pemetrexed for patients with NSCLC? Dr. Mark Kris comments on the findings of this important study. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=5009387 Wed, 06 Jul 2011 16:00:00 +0100 5009387 http://www.medworm.com/index.php?rid=4946235&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F744903%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F744903%3Fsrc%3Drss Dr. David Khayat has been given the Distinguished Achievement Award by ASCO for his role in creating France's National Cancer Institute and spearheading his country's fight against cancer. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4946235 Mon, 20 Jun 2011 14:15:39 +0100 4946235 http://www.medworm.com/index.php?rid=4946236&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F744803%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F744803%3Fsrc%3Drss Estimates from the United States suggest that only about 15% die from the disease; the huge difference is related to prostate-specific antigen testing in asymptomatic men. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4946236 Fri, 17 Jun 2011 12:54:47 +0100 4946236 http://www.medworm.com/index.php?rid=4913061&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F744008%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F744008%3Fsrc%3Drss But with half of the control group crossing over to treatment, how did this affect long-term HERA results? Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4913061 Wed, 08 Jun 2011 14:10:00 +0100 4913061 http://www.medworm.com/index.php?rid=4913063&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F742135%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F742135%3Fsrc%3Drss Dr. Luzia Travado, an expert in psycho-oncology, discusses how treatment plans can be developed to help patients cope with issues arising from the distress they experience from having cancer. ecancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4913063 Tue, 07 Jun 2011 16:00:00 +0100 4913063 http://www.medworm.com/index.php?rid=4913062&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F744112%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F744112%3Fsrc%3Drss John M. Bennett, MD, has been awarded the 2011 B.J. Kennedy Award and Lecture for Scientific Excellence in Geriatric Oncology by the American Society of Clinical Oncology. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4913062 Tue, 07 Jun 2011 12:15:25 +0100 4913062 http://www.medworm.com/index.php?rid=4913064&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F742941%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F742941%3Fsrc%3Drss Hold up a mirror to yourself -- are you suffering from compassion fatigue or burnout? Medscape Nurses (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4913064 Mon, 06 Jun 2011 19:12:00 +0100 4913064 http://www.medworm.com/index.php?rid=4913065&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F744013%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F744013%3Fsrc%3Drss The BRAF inhibitor, with phase 3 data now available, continues to impress with its effectiveness. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4913065 Mon, 06 Jun 2011 15:08:53 +0100 4913065 http://www.medworm.com/index.php?rid=4913066&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F743650%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F743650%3Fsrc%3Drss Despite survival gains, concerns about toxicity and tolerability suggest that patients should be selected carefully for this chemotherapeutic regimen. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4913066 Mon, 06 Jun 2011 13:33:00 +0100 4913066 http://www.medworm.com/index.php?rid=4913067&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F743993%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F743993%3Fsrc%3Drss Postmenopausal women at high risk for breast cancer have a new option for chemoprevention, which appears to be safer and more effective than SERMs. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4913067 Sat, 04 Jun 2011 22:29:35 +0100 4913067 http://www.medworm.com/index.php?rid=4913068&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F743970%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F743970%3Fsrc%3Drss Concerns over potential cross-contamination of nonpenicillin drug products with penicillin have resulted in a nationwide recall of multiple repackaged products. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4913068 Fri, 03 Jun 2011 21:41:42 +0100 4913068 http://www.medworm.com/index.php?rid=4894569&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F743916%3Fsrc%3Drss Dr. John Maris examines the WHO report suggesting a potential link between cell phone use and cancer and asks the question: Is there a physiologic mechanism that could explain a potential association? CHOP Expert Commentary (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4894569 Fri, 03 Jun 2011 18:21:00 +0100 4894569 http://www.medworm.com/index.php?rid=4913069&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F743198%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F743198%3Fsrc%3Drss Whereas most Americans would consider a $160,000 income a fortune, many physicians find it a challenge to live on that amount. Why can some manage easily while others are struggling to pay the bills? Medscape Business of Medicine (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4913069 Fri, 03 Jun 2011 15:49:00 +0100 4913069 http://www.medworm.com/index.php?rid=4913070&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F743915%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F743915%3Fsrc%3Drss The FDA has warned that thermography (the use of infrared cameras to measure heat and blood flow near the body's surface) is not a substitute for mammography. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4913070 Fri, 03 Jun 2011 14:23:58 +0100 4913070 http://www.medworm.com/index.php?rid=4884576&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F743731%3Fsrc%3Drss A new study says that there is some benefit; an expert questions the findings. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4884576 Wed, 01 Jun 2011 14:14:17 +0100 4884576 http://www.medworm.com/index.php?rid=4872963&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F743467%3Fsrc%3Drss High cost sharing and complex drug therapy regimens are significant drivers of patients abandoning oral oncolytic agents. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4872963 Thu, 26 May 2011 17:32:08 +0100 4872963 http://www.medworm.com/index.php?rid=4842485&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F743099%3Fsrc%3Drss The neoadjuvant use of aromatase inhibitors shrinks estrogen-receptor-positive breast tumors, permitting more breast-conserving surgery in postmenopausal women with stage II to III breast cancer. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4842485 Fri, 20 May 2011 14:14:11 +0100 4842485 http://www.medworm.com/index.php?rid=4830560&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F742132%3Fsrc%3Drss Concerned that Federal budget cuts will greatly affect cancer care, Dr. John Marshall challenges oncologists to be proactive and strive to reduce healthcare costs in their practices. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4830560 Fri, 13 May 2011 16:00:00 +0100 4830560 http://www.medworm.com/index.php?rid=4821541&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F742484%3Fsrc%3Drss A new study finds a clear survival benefit with radical prostatectomy vs watchful waiting, but only in men younger than 65. Dr. Gerald Chodak reviews the data. Medscape Urology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4821541 Fri, 13 May 2011 16:00:00 +0100 4821541 http://www.medworm.com/index.php?rid=4821542&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F742168%3Fsrc%3Drss Circulating tumor cells have several potential uses in lung cancer, but are any ready for prime time? Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4821542 Wed, 11 May 2011 14:26:00 +0100 4821542 http://www.medworm.com/index.php?rid=4763370&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F738386%3Fsrc%3Drss Cost-effectiveness models offer a way to objectively examine ovarian cancer management options and give perspective to difficult therapeutic decisions. Cancer Control: Journal of the Moffitt Cancer Center (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4763370 Thu, 28 Apr 2011 16:00:00 +0100 4763370 http://www.medworm.com/index.php?rid=4759266&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F741696%3Fsrc%3Drss Despite NCCN guidelines suggesting that pelvic lymph node dissection (PLND) can be omitted in patients older than 80 years, a retrospective data review shows the elderly also benefit. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4759266 Thu, 28 Apr 2011 14:14:17 +0100 4759266 http://www.medworm.com/index.php?rid=4781856&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F741699%3Fsrc%3Drss The new regulations will have implications for the close to 700,000 prescribers of long-acting and extended-release opioids. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4781856 Thu, 28 Apr 2011 14:12:50 +0100 4781856 http://www.medworm.com/index.php?rid=4759267&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F741382%3Fsrc%3Drss A 43-year-old man presents with abdominal pain, severe intermittent headaches, subjective fever, chills, weakness, reduced appetite, and a 30-lb weight loss over the last few months. What is the diagnosis? Medscape (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4759267 Thu, 28 Apr 2011 13:00:25 +0100 4759267 http://www.medworm.com/index.php?rid=4759268&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F741692%3Fsrc%3Drss Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4759268 Thu, 28 Apr 2011 12:23:27 +0100 4759268 http://www.medworm.com/index.php?rid=4759269&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F741582%3Fsrc%3Drss When fine-needle aspirates of thyroid nodules are inconclusive, FDG-PET scans are sometimes the next step. But how useful they are in this setting isn't completely clear, according to a new meta-analysis from the Netherlands. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4759269 Wed, 27 Apr 2011 21:30:21 +0100 4759269 http://www.medworm.com/index.php?rid=4759270&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F741521%3Fsrc%3Drss Salvage radiotherapy reduces mortality when prostate-specific antigen (PSA) levels are elevated after prostatectomy, even if the rise was a slow one, according to a March 22nd online paper in Cancer. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4759270 Tue, 26 Apr 2011 20:17:54 +0100 4759270 http://www.medworm.com/index.php?rid=4709796&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F738862%3Fsrc%3Drss Despite being an experimental technique, ovarian tissue transplantation after cryopreservation is an option for patients facing chemotherapy. Can it be done without electrocoagulation? Journal of Medical Case Reports (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4709796 Thu, 14 Apr 2011 14:23:48 +0100 4709796 http://www.medworm.com/index.php?rid=4685624&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F740514%3Fsrc%3Drss Data from a large European study suggest that a substantial portion of many common and lethal cancers are caused by alcohol. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4685624 Fri, 08 Apr 2011 14:14:00 +0100 4685624 http://www.medworm.com/index.php?rid=4658994&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F738266%3Fsrc%3Drss The multiple painful skin lesions over the groin area of this patient were initially treated as contact dermatitis, then suspected herpes zoster--but the actual diagnosis was far more ominous. Southern Medical Journal (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4658994 Thu, 31 Mar 2011 14:27:59 +0100 4658994 http://www.medworm.com/index.php?rid=4643773&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F739360%3Fsrc%3Drss More treatment options are good news for patients with breast cancer and bone metastases. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4643773 Tue, 29 Mar 2011 14:09:11 +0100 4643773 http://www.medworm.com/index.php?rid=4643774&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F739515%3Fsrc%3Drss Find out what to do with all of those great ideas. Medscape Anesthesiology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4643774 Tue, 29 Mar 2011 13:25:05 +0100 4643774 http://www.medworm.com/index.php?rid=4611373&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F739177%3Fsrc%3Drss Adding bevacizumab to chemotherapy might help treatment-na�ve patients with locally advanced or metastatic non-small cell lung cancer, Brazilian researchers found in a systematic review. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4611373 Fri, 18 Mar 2011 20:47:33 +0100 4611373 http://www.medworm.com/index.php?rid=4575714&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewcollection%2F31919%3Fsrc%3Drss Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4575714 Fri, 11 Mar 2011 15:55:47 +0100 4575714 http://www.medworm.com/index.php?rid=4571429&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F738811%3Fsrc%3Drss The update incorporates 2 new drugs, and covers several controversial issues in breast cancer, both in surgery and drug treatment. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4571429 Fri, 11 Mar 2011 15:09:47 +0100 4571429 http://www.medworm.com/index.php?rid=4571430&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F738810%3Fsrc%3Drss A shortage of oncologists, increasing costs, and a growing number of patients make it difficult to maintain high-quality cancer care. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4571430 Fri, 11 Mar 2011 14:53:53 +0100 4571430 http://www.medworm.com/index.php?rid=4566845&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F738728%3Fsrc%3Drss The American Cancer Society (ACS) says there should be no debate about screening for colorectal cancer, unlike some other cancers. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4566845 Thu, 10 Mar 2011 15:10:20 +0100 4566845 http://www.medworm.com/index.php?rid=4566846&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F738287%3Fsrc%3Drss Leucovorin, which is used in the treatment of colon cancer, is among the US drugs in short supply. Dr. John Marshall suggests ways that physicians can manage CRC patients without it. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4566846 Wed, 09 Mar 2011 16:09:20 +0100 4566846 http://www.medworm.com/index.php?rid=4561288&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F738510%3Fsrc%3Drss Guess both the patient and his physician's diagnosis in another historical case from this popular series. Medscape General Surgery (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4561288 Wed, 09 Mar 2011 15:10:15 +0100 4561288 http://www.medworm.com/index.php?rid=4561289&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F738649%3Fsrc%3Drss Exercise has long been known to reduce the risk of developing colon cancer; now it appears that it does so by reducing the risk for colon polyps. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4561289 Wed, 09 Mar 2011 13:27:37 +0100 4561289 http://www.medworm.com/index.php?rid=4555012&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F738076%3Fsrc%3Drss Certain healthcare workers are at high risk for inadvertent exposure to hazardous drugs if precautions are not taken. (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4555012 Mon, 07 Mar 2011 15:09:34 +0100 4555012 http://www.medworm.com/index.php?rid=4545411&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F738415%3Fsrc%3Drss Two of the largest studies to date looking at triple-negative breast cancer have found that obesity, physical inactivity, and multiple pregnancies increase the risk for the disease. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4545411 Fri, 04 Mar 2011 15:10:20 +0100 4545411 http://www.medworm.com/index.php?rid=4545412&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F738412%3Fsrc%3Drss Dr. Anil Potti and colleagues have retracted papers from the New England Journal of Medicine, Lancet Oncology, Nature Medicine, and Journal of Clinical Oncology. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4545412 Fri, 04 Mar 2011 13:46:55 +0100 4545412 http://www.medworm.com/index.php?rid=4518095&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F737939%3Fsrc%3Drss Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4518095 Thu, 24 Feb 2011 19:58:49 +0100 4518095 http://www.medworm.com/index.php?rid=4508008&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F737387%3Fsrc%3Drss Dr. Kathy Miller wants to recruit to her staff a fourth-grade student who won top honors in a science fair for her discovery in regard to patients who receive chemotherapy. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4508008 Wed, 23 Feb 2011 14:58:04 +0100 4508008 http://www.medworm.com/index.php?rid=4508009&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F737499%3Fsrc%3Drss Dr. Maurie Markman reviews a recent paper from The New England Journal of Medicine looking at the potential benefits of iniparib in the treatment of triple-negative breast cancer. Medscape Genomic Medicine (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4508009 Wed, 23 Feb 2011 14:39:07 +0100 4508009 http://www.medworm.com/index.php?rid=4502445&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F737588%3Fsrc%3Drss Dr. Mark Kris addresses the primary issues in the treatment of brain metastases including control of local symptoms, prevention of recurrence of brain metastases, and prolongation of life. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4502445 Tue, 22 Feb 2011 14:53:58 +0100 4502445 http://www.medworm.com/index.php?rid=4490470&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F737663%3Fsrc%3Drss Ultrasound fusion imaging was as effective and accurate as computed tomography scans in obtaining musculoskeletal biopsies. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4490470 Fri, 18 Feb 2011 15:09:47 +0100 4490470 http://www.medworm.com/index.php?rid=4490471&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F737661%3Fsrc%3Drss How long does it take to develop expertise? Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4490471 Fri, 18 Feb 2011 13:12:32 +0100 4490471 http://www.medworm.com/index.php?rid=4483931&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F737582%3Fsrc%3Drss More data from a landmark European study of men from the general population and their likelihood of developing prostate cancer. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4483931 Thu, 17 Feb 2011 15:09:56 +0100 4483931 http://www.medworm.com/index.php?rid=4483932&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F737580%3Fsrc%3Drss The US Food and Drug Administration rejected it as a chemopreventive agent for prostate cancer. Can dutasteride live up to its billing in another trial? Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4483932 Thu, 17 Feb 2011 13:32:58 +0100 4483932 http://www.medworm.com/index.php?rid=4483933&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F735826%3Fsrc%3Drss Patients with extensive actinic damage who are at high risk for nonmelanoma skin cancers may have cause for celebration - with celecoxib. Journal of the National Cancer Institute (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4483933 Tue, 15 Feb 2011 17:00:00 +0100 4483933 http://www.medworm.com/index.php?rid=4455951&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F737130%3Fsrc%3Drss Dr. David Johnson comments on a new study where a dog detected colon cancer in breath and stool samples with high accuracy. Will scent detection play a role in future diagnostic screening? Medscape Gastroenterology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4455951 Thu, 10 Feb 2011 15:09:39 +0100 4455951 http://www.medworm.com/index.php?rid=4451069&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F737099%3Fsrc%3Drss Axillary lymph node dissection is the gold standard when sentinel nodes are positive -- except in these cases. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4451069 Wed, 09 Feb 2011 15:09:26 +0100 4451069 http://www.medworm.com/index.php?rid=4460669&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F737099%3Fsrc%3Drss Axillary lymph node dissection is the gold standard when sentinel nodes are positive -- except in these cases. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4460669 Wed, 09 Feb 2011 13:58:20 +0100 4460669 http://www.medworm.com/index.php?rid=4451070&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F737096%3Fsrc%3Drss Early infusion of donor T-regulatory cells in leukemia patients undergoing hematopoietic stem cell transplantation can hasten immune recovery. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4451070 Wed, 09 Feb 2011 13:10:24 +0100 4451070 http://www.medworm.com/index.php?rid=4442571&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F736675%3Fsrc%3Drss Commentary on a study on whether local excision provides similar outcomes to radical surgery in patients with rectal cancer who respond to chemoradiation, published in the British Journal of Surgery. Medscape General Surgery (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4442571 Mon, 07 Feb 2011 15:09:39 +0100 4442571 http://www.medworm.com/index.php?rid=4433423&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F736870%3Fsrc%3Drss In the near future, the majority of new cancer cases will occur in developing nations; African countries are the least able to cope. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4433423 Fri, 04 Feb 2011 15:09:45 +0100 4433423 http://www.medworm.com/index.php?rid=4433424&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F736869%3Fsrc%3Drss Recent global cancer statistics show the scale of the problem worldwide, and also how cancers vary worldwide. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4433424 Fri, 04 Feb 2011 14:49:54 +0100 4433424 http://www.medworm.com/index.php?rid=4433425&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F736868%3Fsrc%3Drss The prep pads were voluntarily removed from the market due to possible contamination with bacteria. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4433425 Fri, 04 Feb 2011 14:41:12 +0100 4433425 http://www.medworm.com/index.php?rid=4433426&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F736503%3Fsrc%3Drss Is colon capsule endoscopy as effective as a colonoscopy in diagnosing colorectal cancer? Alimentary Pharmacology & Therapeutics (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4433426 Fri, 04 Feb 2011 04:00:00 +0100 4433426 http://www.medworm.com/index.php?rid=4433428&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F736782%3Fsrc%3Drss Prostate tumors with a distinctive four-gene "signature" are far more lethal than others, laying the groundwork for a test to predict which tumors need aggressive treatment, U.S. researchers said on Wednesday. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4433428 Thu, 03 Feb 2011 22:00:50 +0100 4433428 http://www.medworm.com/index.php?rid=4433427&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F736813%3Fsrc%3Drss A new study questions the USPTF mammography recommendations and shows that annual screening beginning at an earlier age results in more lives saved. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4433427 Thu, 03 Feb 2011 21:36:54 +0100 4433427 http://www.medworm.com/index.php?rid=4415236&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F735151%3Fsrc%3Drss Do colonoscopies reduce mortality from colorectal cancer? This new study looks at the latest data. The American Journal of Gastroenterology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4415236 Mon, 31 Jan 2011 04:00:00 +0100 4415236 http://www.medworm.com/index.php?rid=4400462&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F736089%3Fsrc%3Drss The long-term risk of dying of cardiac disease is a concern for women treated for a left-sided breast cancer with contemporary breast or chest radiotherapy. Journal of the American College of Cardiology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4400462 Wed, 26 Jan 2011 22:33:01 +0100 4400462 http://www.medworm.com/index.php?rid=4314646&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F735352%3Fsrc%3Drss If you have been to the San Antonio Breast Cancer Symposium (SABCS), then you know his voice. Now meet the man. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4314646 Thu, 06 Jan 2011 15:09:11 +0100 4314646 http://www.medworm.com/index.php?rid=4314647&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F735345%3Fsrc%3Drss Recent surveys show that oncologists discuss the potential impact of cancer treatment on fertility, but less than half refer patients to reproductive specialists. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4314647 Thu, 06 Jan 2011 14:01:30 +0100 4314647 http://www.medworm.com/index.php?rid=4305221&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F735139%3Fsrc%3Drss The European Commission has approved nilotinib for the first-line treatment of chronic-phase Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in adults. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4305221 Mon, 03 Jan 2011 21:08:48 +0100 4305221 http://www.medworm.com/index.php?rid=4305222&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734957%3Fsrc%3Drss Investigators tease out the relationship between infertility, androgen excess, and risk for certain cancers. Medscape Ob/Gyn & Women's Health (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4305222 Mon, 03 Jan 2011 20:09:41 +0100 4305222 http://www.medworm.com/index.php?rid=4305223&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F735137%3Fsrc%3Drss Children who were exposed to radiation of the head and neck have an increased risk for thyroid cancer that lasts well into late adulthood. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4305223 Mon, 03 Jan 2011 20:06:43 +0100 4305223 http://www.medworm.com/index.php?rid=4305227&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734141%3Fsrc%3Drss Prostate cancer has been proposed as a model of "epigenetic catastrophe." Widespread changes in DNA methylation patterns make prostate cancer an attractive disease for epigenetic drug targets. Nature Reviews Urology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4305227 Mon, 03 Jan 2011 04:00:00 +0100 4305227 http://www.medworm.com/index.php?rid=4305226&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F733796%3Fsrc%3Drss Can collections of cell lines representing multiple cell types be used to model the cellular heterogeneity of tissues? Breast Cancer Research (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4305226 Mon, 03 Jan 2011 04:00:00 +0100 4305226 http://www.medworm.com/index.php?rid=4305225&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734129%3Fsrc%3Drss This article examines the role that KRAS plays in the biology of PDAC. Nature Reviews Cancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4305225 Mon, 03 Jan 2011 04:00:00 +0100 4305225 http://www.medworm.com/index.php?rid=4305224&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734593%3Fsrc%3Drss This study describes how patients with HIV infection may be susceptible to contracting cancers of various kinds. HIV Therapy (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4305224 Mon, 03 Jan 2011 04:00:00 +0100 4305224 http://www.medworm.com/index.php?rid=4300830&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F735089%3Fsrc%3Drss Trabectedin increased progression-free survival in patients with partially platinum-sensitive, relapsed ovarian cancer. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4300830 Fri, 31 Dec 2010 21:08:45 +0100 4300830 http://www.medworm.com/index.php?rid=4300831&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F735088%3Fsrc%3Drss A large prospective study shows that the use of vitamin supplements reduced mortality and recurrence in the first 6 months after diagnosis. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4300831 Fri, 31 Dec 2010 03:28:59 +0100 4300831 http://www.medworm.com/index.php?rid=4298931&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734943%3Fsrc%3Drss A woman's medical history provides clues to the cause of her embarrassing tooth and gingival discoloration. Medscape Dentistry & Oral Health (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4298931 Thu, 30 Dec 2010 21:09:06 +0100 4298931 http://www.medworm.com/index.php?rid=4298932&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F735043%3Fsrc%3Drss A study suggests a new therapeutic approach to restrain oncogenic signaling in glioblastoma. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4298932 Thu, 30 Dec 2010 17:55:34 +0100 4298932 http://www.medworm.com/index.php?rid=4298933&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F735041%3Fsrc%3Drss IDH1R132 and IDH2R172 mutations were most often detected in cytogenetically normal acute myeloid leukemia cases with an overall frequency of approximately 11.8%. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4298933 Thu, 30 Dec 2010 17:22:29 +0100 4298933 http://www.medworm.com/index.php?rid=4298934&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F733282%3Fsrc%3Drss Cytotoxic drugs, radiotherapy, and hemopoietic stem cell transplantation are all potential causes of nephrotoxicity in children with cancer. How can the risks be minimized? Pediatric Health (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4298934 Thu, 30 Dec 2010 04:01:00 +0100 4298934 http://www.medworm.com/index.php?rid=4298937&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F733081%3Fsrc%3Drss Radiation exposure over time may have different effects than previously thought. Journal of the National Cancer Institute (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4298937 Thu, 30 Dec 2010 04:00:00 +0100 4298937 http://www.medworm.com/index.php?rid=4298936&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F733882%3Fsrc%3Drss Rhabdomyosarcoma and schwannoma are two of the rarer tumors seen in the surgical setting, and even more rarely seen in the breast. Southern Medical Journal (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4298936 Thu, 30 Dec 2010 04:00:00 +0100 4298936 http://www.medworm.com/index.php?rid=4298935&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F732560%3Fsrc%3Drss A male patient presented with a perplexing case of Lambert Eaton myasthenic syndrome. What did the PET-CT scan reveal? Journal of Medical Case Reports (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4298935 Thu, 30 Dec 2010 04:00:00 +0100 4298935 http://www.medworm.com/index.php?rid=4295206&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734799%3Fsrc%3Drss Are physicians giving patients enough information -- including their own procedure rates -- to help them make informed choices on prostate cancer treatments? Dr. Gerald Chodak discusses this controversial issue. Medscape Urology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4295206 Wed, 29 Dec 2010 21:09:19 +0100 4295206 http://www.medworm.com/index.php?rid=4295207&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734949%3Fsrc%3Drss CMS resurrects a controversial measure stripped from healthcare reform legislation that would reimburse physicians for talking to Medicare patients about their choices for end-of-life treatment. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4295207 Wed, 29 Dec 2010 19:45:37 +0100 4295207 http://www.medworm.com/index.php?rid=4295208&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734934%3Fsrc%3Drss Patients with cancer who continue to smoke despite their diagnosis experience greater pain severity than those who quit or who have never smoked. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4295208 Wed, 29 Dec 2010 15:58:09 +0100 4295208 http://www.medworm.com/index.php?rid=4295209&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734933%3Fsrc%3Drss Patients with follicular lymphoma receiving rituximab maintenance therapy had significantly better progression-free survival but not overall survival. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4295209 Wed, 29 Dec 2010 14:40:23 +0100 4295209 http://www.medworm.com/index.php?rid=4295210&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734327%3Fsrc%3Drss Can genotyping reduce ADRs associated with fluorouracil? Pharmacogenomics (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4295210 Wed, 29 Dec 2010 04:00:00 +0100 4295210 http://www.medworm.com/index.php?rid=4295211&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734860%3Fsrc%3Drss Older prostate cancer patients who opt for androgen deprivation therapy might be slightly raising their risk of developing cataracts, a new study suggests. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4295211 Wed, 29 Dec 2010 03:00:03 +0100 4295211 http://www.medworm.com/index.php?rid=4275620&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734527%3Fsrc%3Drss Men who screen negative for lung cancer are less likely to try to quit smoking than men whose scans are inconclusive, a Dutch study shows. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4275620 Tue, 21 Dec 2010 04:26:16 +0100 4275620 http://www.medworm.com/index.php?rid=4272688&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734221%3Fsrc%3Drss Dr. Maurie Markman reports on a Swedish study that presents conclusive findings concerning in vitro fertilization and the risk for ovarian cancer. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4272688 Mon, 20 Dec 2010 15:08:38 +0100 4272688 http://www.medworm.com/index.php?rid=4266813&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F728479%3Fsrc%3Drss These commentaries from the Faculty of 1000 cover an important study suggesting that early palliative care in metastatic lung cancer my prolong survival. Faculty of 1000 Medicine (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266813 Sun, 19 Dec 2010 13:09:12 +0100 4266813 http://www.medworm.com/index.php?rid=4266814&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734403%3Fsrc%3Drss Dr. Gunter von Minckwitz discusses with Dr. Kathy Miller the findings of the GeparQuinto trial in which bevacizumab was used in combination with chemotherapy in early-stage breast cancer. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266814 Fri, 17 Dec 2010 20:54:36 +0100 4266814 http://www.medworm.com/index.php?rid=4266815&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734192%3Fsrc%3Drss Andrew Vickers, Medscape's biostatistician, strolls down Brooklyn sidewalks swigging multiple cups of coffee and asking, "Am I preventing advanced prostate cancer?" Medscape Business of Medicine (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266815 Fri, 17 Dec 2010 20:41:13 +0100 4266815 http://www.medworm.com/index.php?rid=4266816&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734171%3Fsrc%3Drss Dr. Maurie Markman looks back at key research studies from 2010 and discusses how they affect our understanding of the role of cancer genomics in clinical practice. Medscape Genomic Medicine (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266816 Fri, 17 Dec 2010 20:38:30 +0100 4266816 http://www.medworm.com/index.php?rid=4266817&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F733488%3Fsrc%3Drss Commentary on a study on whether the recent decline in breast cancer mortality is due to screening mammography and earlier diagnosis or better treatments. Medscape General Surgery (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266817 Fri, 17 Dec 2010 19:11:05 +0100 4266817 http://www.medworm.com/index.php?rid=4266818&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734368%3Fsrc%3Drss Dr. George Sledge, recipient of the William L. McGuire Memorial Lecture, discusses with Dr. Kathy Miller the lessons learned from Bill McGuire about translational research. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266818 Fri, 17 Dec 2010 18:02:05 +0100 4266818 http://www.medworm.com/index.php?rid=4266819&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734404%3Fsrc%3Drss Dr. Kathy Miller discusses with Dr. Jose Baselga and ASCO® president Dr. George Sledge 3 important trials looking at therapy for breast cancer in the adjuvant and neoadjuvant settings. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266819 Fri, 17 Dec 2010 17:56:13 +0100 4266819 http://www.medworm.com/index.php?rid=4266821&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F730180%3Fsrc%3Drss This study looks at the potential of polymersomes to deliver chemotherapeutic agents or gene therapy intracellularly in oral squamous cell carcinoma, a common cancer with a poor prognosis. Nanomedicine (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266821 Fri, 17 Dec 2010 17:00:00 +0100 4266821 http://www.medworm.com/index.php?rid=4266820&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F733943%3Fsrc%3Drss Dr. John Marshall addresses the issue of how to define the value of drugs and proposes a scorecard by which regulators would have multiple targets to define the worth of drugs for approval purposes. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266820 Fri, 17 Dec 2010 15:43:30 +0100 4266820 http://www.medworm.com/index.php?rid=4266823&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734061%3Fsrc%3Drss While the prognosis of chronic myeloid leukemia has dramatically improved with tyrosine kinase inhibitors, they have also been implicated in a higher risk of later cancers. What's the correlation? American Journal of Epidemiology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266823 Fri, 17 Dec 2010 04:00:00 +0100 4266823 http://www.medworm.com/index.php?rid=4266822&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F731446%3Fsrc%3Drss The authors of this News & Views article raise important issues about how to validate the clinical utility of the new molecular classifiers for risk prediction. Nature Reviews Clinical Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266822 Fri, 17 Dec 2010 04:00:00 +0100 4266822 http://www.medworm.com/index.php?rid=4266824&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734382%3Fsrc%3Drss Mutations in FP/TMEM127 were associated with pheochromocytoma in patients with median age in the early 40s; a group that is often ignored in genetic screening programs. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266824 Thu, 16 Dec 2010 19:29:31 +0100 4266824 http://www.medworm.com/index.php?rid=4266825&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734315%3Fsrc%3Drss Dr. Luca Gianni discusses with Dr. Kathy Miller the NeoSphere study presented at 2010 SABCS, which showed a doublet of monoclonal antibodies can eradicate HER2-positive tumors in a subset of patients. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266825 Thu, 16 Dec 2010 19:05:08 +0100 4266825 http://www.medworm.com/index.php?rid=4266826&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734381%3Fsrc%3Drss Zoledronic acid used with induction chemotherapy significantly improved survival in newly diagnosed patients, compared with a regimen that included clodronate. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266826 Thu, 16 Dec 2010 18:53:53 +0100 4266826 http://www.medworm.com/index.php?rid=4266827&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734051%3Fsrc%3Drss What are the implications of a small but significant increased risk for cancer after these life-saving tests and procedures? Medscape Radiology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266827 Thu, 16 Dec 2010 17:31:29 +0100 4266827 http://www.medworm.com/index.php?rid=4266828&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734373%3Fsrc%3Drss The FDA has announced that it will take the first steps to remove the indication for bevacizumab (Avastin) in metastatic breast cancer. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266828 Thu, 16 Dec 2010 17:16:37 +0100 4266828 http://www.medworm.com/index.php?rid=4266829&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734357%3Fsrc%3Drss In a study, hysterectomy for reasons other than cancer was significantly related to renal cell carcinoma; younger women undergoing the procedure faced greatest risk. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4266829 Thu, 16 Dec 2010 17:09:58 +0100 4266829 http://www.medworm.com/index.php?rid=4253524&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734113%3Fsrc%3Drss Dasatinib continues to demonstrate superior efficacy compared with imatinib in patients with newly diagnosed CML. However, survival rates between dasatinib and imatinib are similar. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4253524 Mon, 13 Dec 2010 19:09:09 +0100 4253524 http://www.medworm.com/index.php?rid=4259269&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F734113%3Fsrc%3Drss Dasatinib continues to demonstrate superior efficacy compared with imatinib in patients with newly diagnosed CML. However, survival rates between dasatinib and imatinib are similar. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4259269 Mon, 13 Dec 2010 17:56:43 +0100 4259269 http://www.medworm.com/index.php?rid=4233818&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F733732%3Fsrc%3Drss The largest study to date of volunteer unrelated donors found no increase in cancer or health problems. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4233818 Tue, 07 Dec 2010 13:08:42 +0100 4233818 http://www.medworm.com/index.php?rid=4225671&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F732607%3Fsrc%3Drss Is there value in a risk-based approach to thrombophilia evaluation in children? Medscape Pediatrics (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4225671 Fri, 03 Dec 2010 21:08:31 +0100 4225671 http://www.medworm.com/index.php?rid=4225672&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F733487%3Fsrc%3Drss Dr. Kathy Miller gives an overview of key studies to be presented at SABCS, which this year highlight breast cancer therapy in the adjuvant and neoadjuvant settings. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4225672 Fri, 03 Dec 2010 17:03:58 +0100 4225672 http://www.medworm.com/index.php?rid=4225674&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F733549%3Fsrc%3Drss The current shortage of intravenous generic drugs in the United States is hitting oncology and critical care the hardest. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4225674 Fri, 03 Dec 2010 15:49:42 +0100 4225674 http://www.medworm.com/index.php?rid=4200934&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F732980%3Fsrc%3Drss There appear to be several problems with the current clinical staging criteria for localized prostate cancer, according to a study published online today in the November 22 Cancer. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4200934 Thu, 25 Nov 2010 18:18:23 +0100 4200934 http://www.medworm.com/index.php?rid=4144447&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F732102%3Fsrc%3Drss Women undergoing reconstruction after double mastectomy for breast cancer are more satisfied with silicone gel implants than those filled with saline. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4144447 Mon, 08 Nov 2010 17:31:24 +0100 4144447 http://www.medworm.com/index.php?rid=4152558&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F732119%3Fsrc%3Drss A new study is the strongest to date on smoking and breast cancer mortality. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4152558 Mon, 08 Nov 2010 17:00:00 +0100 4152558 http://www.medworm.com/index.php?rid=4109377&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F731550%3Fsrc%3Drss The miss rate for polyps on colonoscopy was 13.6% on forward inspection only, compared with a retroflexion technique. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4109377 Fri, 29 Oct 2010 15:59:13 +0100 4109377 http://www.medworm.com/index.php?rid=4109378&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F731495%3Fsrc%3Drss The contaminated antimetabolite could trigger a variety of serious adverse events, depending on the kind of parenteral administration. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4109378 Fri, 29 Oct 2010 15:51:49 +0100 4109378 http://www.medworm.com/index.php?rid=4109379&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F731493%3Fsrc%3Drss Medicare Part B ranks highest overall among medical practice managers' payers with regard to prompt payment and overall satisfaction compared with payers in the private sector. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4109379 Fri, 29 Oct 2010 15:41:47 +0100 4109379 http://www.medworm.com/index.php?rid=4109380&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F731251%3Fsrc%3Drss There was a 43% lower estrogen receptor-negative/progesterone receptor-negative breast cancer risk with high vegetable intake but no association of total fruit/vegetable intake with overall risk. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4109380 Wed, 27 Oct 2010 17:01:00 +0100 4109380 http://www.medworm.com/index.php?rid=4089137&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F729406%3Fsrc%3Drss A nurse shares her personal experience and provides objective information to help others cope with death, dying, and grief.   Oncology Nursing Forum (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4089137 Fri, 22 Oct 2010 16:00:00 +0100 4089137 http://www.medworm.com/index.php?rid=4089136&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F729792%3Fsrc%3Drss Measurement of patient-reported outcomes, mostly described as the physical, social, emotional and functional wellbeing of the patient, are vital signs of effective care management. Future Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4089136 Fri, 22 Oct 2010 16:00:00 +0100 4089136 http://www.medworm.com/index.php?rid=4089135&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F729790%3Fsrc%3Drss EGFR is one of the most studied targets in oncology, and several inhibitors have shown promising results in selected patient populations. However resistance to these targeted therapies is increasingly recognized. Nature Reviews Clinical Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4089135 Fri, 22 Oct 2010 16:00:00 +0100 4089135 http://www.medworm.com/index.php?rid=4089134&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F729640%3Fsrc%3Drss A 46-year-old woman presented with a painless breast lump, but FDG PET/CT scanning revealed some surprising findings. Journal of Medical Case Reports (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4089134 Fri, 22 Oct 2010 16:00:00 +0100 4089134 http://www.medworm.com/index.php?rid=4089138&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F730869%3Fsrc%3Drss A small study has found that breast-feeding after treatment for breast cancer is not associated with an increased risk for disease recurrence. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4089138 Wed, 20 Oct 2010 18:37:51 +0100 4089138 http://www.medworm.com/index.php?rid=4082624&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F730017%3Fsrc%3Drss While type 1 hemochromatosis is the most common of the genetic iron overload diseases, it's not the only one. How is molecular diagnostics being used to differentiate them? Expert Review of Molecular Diagnostics (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines news http://www.medworm.com/rss/comments.php?id=4082624 Wed, 20 Oct 2010 10:09:05 +0100 4082624